CA2578313A1 - Dispositif de dosage immunologique parallele rapide et tres precis - Google Patents
Dispositif de dosage immunologique parallele rapide et tres precis Download PDFInfo
- Publication number
- CA2578313A1 CA2578313A1 CA 2578313 CA2578313A CA2578313A1 CA 2578313 A1 CA2578313 A1 CA 2578313A1 CA 2578313 CA2578313 CA 2578313 CA 2578313 A CA2578313 A CA 2578313A CA 2578313 A1 CA2578313 A1 CA 2578313A1
- Authority
- CA
- Canada
- Prior art keywords
- test device
- antigens
- immobilized
- disease
- flow
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000003018 immunoassay Methods 0.000 title 1
- 239000000427 antigen Substances 0.000 claims abstract description 54
- 102000036639 antigens Human genes 0.000 claims abstract description 54
- 108091007433 antigens Proteins 0.000 claims abstract description 54
- 201000010099 disease Diseases 0.000 claims abstract description 36
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 36
- 239000003550 marker Substances 0.000 claims abstract description 21
- 238000012360 testing method Methods 0.000 claims description 77
- 239000012528 membrane Substances 0.000 claims description 35
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 17
- 210000004369 blood Anatomy 0.000 claims description 9
- 239000008280 blood Substances 0.000 claims description 9
- 210000002966 serum Anatomy 0.000 claims description 8
- 210000001124 body fluid Anatomy 0.000 claims description 2
- 210000003296 saliva Anatomy 0.000 claims description 2
- 210000002700 urine Anatomy 0.000 claims description 2
- 241000894006 Bacteria Species 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 210000004927 skin cell Anatomy 0.000 claims 1
- 238000002405 diagnostic procedure Methods 0.000 abstract description 5
- 238000001514 detection method Methods 0.000 abstract description 3
- 241000713772 Human immunodeficiency virus 1 Species 0.000 description 10
- 241000725303 Human immunodeficiency virus Species 0.000 description 8
- 239000002250 absorbent Substances 0.000 description 7
- 230000002745 absorbent Effects 0.000 description 7
- 239000003153 chemical reaction reagent Substances 0.000 description 7
- 239000000463 material Substances 0.000 description 6
- 230000035945 sensitivity Effects 0.000 description 6
- 239000000872 buffer Substances 0.000 description 5
- 230000003100 immobilizing effect Effects 0.000 description 5
- 241000713340 Human immunodeficiency virus 2 Species 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 208000031886 HIV Infections Diseases 0.000 description 3
- 101800000385 Transmembrane protein Proteins 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- 208000035473 Communicable disease Diseases 0.000 description 2
- 208000037357 HIV infectious disease Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 2
- 238000012125 lateral flow test Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—HIV or HTLV
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
- G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
- G01N2333/16—HIV-1, HIV-2
- G01N2333/162—HIV-1, HIV-2 env, e.g. gp160, gp110/120, gp41, V3, peptid T, DC4-Binding site
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Virology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA 2578313 CA2578313A1 (fr) | 2007-03-01 | 2007-03-01 | Dispositif de dosage immunologique parallele rapide et tres precis |
| PCT/CA2008/000391 WO2008104081A1 (fr) | 2007-03-01 | 2008-02-29 | Dispositif de dosage immunologique parallèle |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA 2578313 CA2578313A1 (fr) | 2007-03-01 | 2007-03-01 | Dispositif de dosage immunologique parallele rapide et tres precis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2578313A1 true CA2578313A1 (fr) | 2007-05-14 |
Family
ID=38051491
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA 2578313 Abandoned CA2578313A1 (fr) | 2007-03-01 | 2007-03-01 | Dispositif de dosage immunologique parallele rapide et tres precis |
Country Status (2)
| Country | Link |
|---|---|
| CA (1) | CA2578313A1 (fr) |
| WO (1) | WO2008104081A1 (fr) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016035099A1 (fr) * | 2014-09-05 | 2016-03-10 | Meril Diagnostics Private Limited | Dispositif à flux traversant pour la détection de substances biologiques à analyser et procédé associé |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3746787A4 (fr) * | 2018-02-01 | 2021-12-01 | Sedia Biosciences Corporation | Dosage quantitatif rapide permettant l'évaluation de la durée d'une infection |
| US11011278B1 (en) | 2020-09-21 | 2021-05-18 | Biolytical Laboratories Inc. | Methods and rapid test kits facilitating epidemiological surveillance |
| CN113311159A (zh) * | 2021-04-15 | 2021-08-27 | 南方医科大学 | 通过血清hiv-1抗体检测快速区分hiv近期和长期感染状态的试纸条及其制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001095784A2 (fr) * | 2000-06-14 | 2001-12-20 | J.Mitra & Co. Ltd. | Trousse de diagnostic destinee a la detection in vitro de l'hepatite c |
| DE10108680A1 (de) * | 2001-02-23 | 2002-09-26 | Biognostic Ag | Affinitätsassay zur schnellen Untersuchung biologischer Materialien |
| CN1164949C (zh) * | 2001-08-17 | 2004-09-01 | 上海数康生物科技有限公司 | 用于同时检测多种传染性疾病的试剂盒及其制备方法 |
| EP1787121B1 (fr) * | 2004-07-29 | 2010-08-25 | Relia Diagnostic Systems, LLC | Systeme et dispositif d'analyse sur membrane |
| CA2589759A1 (fr) * | 2004-12-04 | 2006-06-15 | Freedom Health, Llc | Anticorps monoclonaux et polyclonaux contre l'hemoglobine equine ainsi qu'appareil et procedes permettant d'utiliser ces anticorps et/ou des reactions de peroxydase dans l'identification et la localisation d'ulceres chez les chevaux |
| CN1773285A (zh) * | 2005-11-02 | 2006-05-17 | 中国农业科学院生物技术研究所 | 一种联检epsps和bt蛋白的试剂盒及方法 |
| EP1798556B1 (fr) * | 2005-12-14 | 2009-08-26 | The Jordanian Pharmaceutical Manufacturing Co. | Dispositif pour la détection immunochromatographique précoce et rapide de l HIV, et usages correspondants |
-
2007
- 2007-03-01 CA CA 2578313 patent/CA2578313A1/fr not_active Abandoned
-
2008
- 2008-02-29 WO PCT/CA2008/000391 patent/WO2008104081A1/fr active Application Filing
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016035099A1 (fr) * | 2014-09-05 | 2016-03-10 | Meril Diagnostics Private Limited | Dispositif à flux traversant pour la détection de substances biologiques à analyser et procédé associé |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008104081A1 (fr) | 2008-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2332523T3 (es) | Metodo para el diagnostico rapido de blancos en fluidos corporales humanos. | |
| AU2014226173B2 (en) | Method and device for combined detection of viral and bacterial infections | |
| US10379121B2 (en) | Method and device for combined detection of viral and bacterial infections | |
| US8962260B2 (en) | Method and device for combined detection of viral and bacterial infections | |
| US7579195B2 (en) | Simple membrane assay method and kit | |
| CA2578313A1 (fr) | Dispositif de dosage immunologique parallele rapide et tres precis | |
| WO2006073153A1 (fr) | Procédé d’analyse simplifié pour détecter de multiples sujets | |
| WO2006043614A1 (fr) | Procédé d’immunoanalyse de membrane | |
| US9404923B2 (en) | Mycobacterium tuberculosis specific peptides for detection of infection or immunization in non-human primates | |
| JP2004028875A (ja) | 簡易メンブレンアッセイ法及びキット | |
| CN117110604A (zh) | 检测新冠病毒抗原的免疫层析试纸条 | |
| Burgess-Cassler et al. | A field test for the detection of antibodies to human immunodeficiency virus types 1 and 2 in serum or plasma | |
| EP2200620A1 (fr) | Recherche de maladie infectieuse dans du liquide menstruel, des cellules endométriales/menstruelles, du liquide amniotique, du sang de cordon ombilical ou d'autres échantillons | |
| Jesadiya | In vitro Diagnosis in SR BIOERA | |
| WO2022027088A1 (fr) | Dispositif à écoulement latéral et ses utilisations | |
| EA042747B1 (ru) | Способ и устройство для дифференцировки вирусных инфекций от бактериальных инфекций |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Dead |